Loading...
*  CD177
Pahl HL (2003). "PRV-1 mRNA expression and other molecular markers in polycythemia rubra vera". Curr. Hematol. Rep. 2 (3): 231- ... 2003). "Fluorescence in situ hybridization analysis of the PRV-1 gene in polycythemia vera: implications for its role in ... 2002). "Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia". J. Clin. Oncol. 20 (20): 4249-54. ... which is overexpressed in polycythemia rubra vera". Blood. 95 (8): 2569-76. PMID 10753836. Lalezari P, Murphy GB, Allen FH Jr ( ...
*  Janus kinase 2
Jak2 mutation, when demonstrable, is one of the methods of diagnosing polycythemia vera. Janus kinase 2 has been shown to ... Pargade V, Darnige L, Gaussem P (2006). "[Acquired mutation of JAK2 tyrosine kinase and polycythaemia vera]". Annales De ... Mutations in JAK2 have been implicated in polycythemia vera, essential thrombocythemia, and myelofibrosis as well as other ...
*  Essential thrombocytosis
No evidence of polycythemia vera hematocrit < midpoint of normal range or normal red cell mass in presence of normal iron ... Vannucchi, AM (June 2010). "Insights into the pathogenesis and management of thrombosis in polycythemia vera and essential ... Campbell PJ, Green AR (2005). "Management of polycythemia vera and essential thrombocythemia" (PDF). Hematology / the Education ... polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management". American ...
*  Ruxolitinib
In 2014, it was approved in polycythemia vera (PCV) when there has been an inadequate response to or intolerance of hydroxyurea ... 2015). "Ruxolitinib versus standard therapy for the treatment of polycythemia vera". N. Engl. J. Med. 372 (5): 426-35. doi: ... and for polycythemia vera (PCV) when there has been an inadequate response to or intolerance of hydroxyurea. Ruxolitinib is a ...
*  Janus kinase
JAK inhibitors are under development for the treatment of psoriasis, rheumatoid arthritis, polycythemia vera, alopecia, ...
*  Polycythemia vera
... : Definition. Mayo Clinic. Retrieved 2011-09-03. "What Is Polycythemia Vera?". What Is Polycythemia Vera?. ... People with polycythemia vera can be asymptomatic. A classic symptom of polycythemia vera is pruritus or itching, particularly ... "Polycythemia Vera Follow-up". Polycythemia Vera Follow-up. Retrieved 2011-09-03. Streiff MB, Smith B, Spivak JL (2002). "The ... JAK2-positive polycythaemia vera - diagnosis requires both criteria to be present: JAK2-negative polycythemia vera - diagnosis ...
*  List of OMIM disorder codes
FST Polycythemia vera; 263300; JAK2 Polycythemia, benign familial; 263400; VHL Polydactyly, postaxial, types A1 and B; 174200; ...
*  Aquagenic pruritus
Some of which includes polycythemia vera. Since pruritus is a symptom of many serious diseases, it is important to rule out ...
*  Givinostat
... including polycythaemia vera. In patients with polycythaemia, the reduction of mutant JAK2 concentrations by givinostat is ... "Treatment options for essential thrombocythemia and polycythemia vera". Expert Review of Hematology. 2 (1): 41-55. doi:10.1586/ ... Givinostat for the treatment of polycythaemia vera" (PDF). European Medicines Agency. WO patent application 1997/043251, " ... drug designation in the European Union for the treatment of systemic juvenile idiopathic arthritis and polycythaemia vera. ...
*  Mir-339 microRNA precursor family
"Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis". Experimental Hematology. 35 (11): 1657-1667 ...
*  Erlotinib
JAK2V617F is a mutant of tyrosine kinase JAK2, is found in most patients with polycythemia vera (PV) and a substantial ... "Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth". J Biol Chem. 282 (6): 3428-32. doi: ...
*  Ranimustine
December 1988). "[Therapeutic effect of ranimustine (MCNU) on essential thrombocythemia and polycythemia vera]". Gan To Kagaku ... is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera. It ...
*  Pipobroman
Passamonti, F.; Lazzarino, M. (2003). "Treatment of Polycythemia Vera and Essential Thrombocythemia: The Role of Pipobroman". ...
*  Hemorheology
Tefferi A (May 2003). "A contemporary approach to the diagnosis and management of polycythemia vera". Curr. Hematol. Rep. 2 (3 ... When the hematocrit rises to 60 or 70%, which it often does in polycythemia, the blood viscosity can become as great as 10 ...
*  Myelofibrosis
Najean Y, Rain JD (1997). "Treatment of polycythemia vera: the use of hydroxyurea and piprobroman in 292 patients under the age ... Primary myelofibrosis can begin with a blood picture similar to that found in polycythemia vera or chronic myelogenous leukemia ... Myelofibrosis can be a late complication of other myeloproliferative disorders, such as polycythemia vera, and less commonly, ... This is in contrast with myelofibrosis that develops secondary to polycythemia vera or essential thrombocythaemia. ...
*  Myeloproliferative neoplasm
Patients with JAK2V617F-negative polycythemia vera are instead positive for another class of activating JAK2 mutations - the ... 2007). "JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis". N. Engl. J. Med. 356 (5): 459-68. doi: ... 2005). "Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation ... 2005). "A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera". Nature. 434 (7037): 1144- ...
*  Capillary leak syndrome
It is often misdiagnosed as polycythemia, polycythemia vera, hyperviscosity syndrome, or sepsis. Most SCLS patients report ...
*  Bcl-xL
February 26, 1998). "Expression of Bcl-x in erythroid precursors from patients with polycythemia vera". New England Journal of ... suggested to play additional roles in regulating this process in erythrocytes which could lead to a role in polycythemia vera, ...
*  Budd-Chiari syndrome
Many patients have Budd-Chiari syndrome as a complication of polycythemia vera (myeloproliferative disease of red blood cells ... Progressive abdominal distention in a 51-year-old woman with polycythemia vera". "Hepatic outflow obstruction (Budd-Chiari ... Polycythemia vera Pregnancy Postpartum state Use of oral contraceptives Paroxysmal nocturnal hemoglobinuria Hepatocellular ...
*  Diffusing capacity
Burgess, J. H.; Bishop, J. M. "PULMONARY DIFFUSING CAPACITY AND ITS SUBDIVISIONS IN POLYCYTHEMIA VERA". Journal of Clinical ... polycythemia, left to right intracardiac shunts, due increase in volume of blood exposed to inspired gas. Asthma due to better ... More hemoglobin is present in polycythemia, and so D L C O {\displaystyle D_{L_{CO}}} is elevated. In anemia, the opposite is ...
*  Amaurosis fugax
"Peripheral arterial occlusion and amaurosis fugax as the first manifestation of polycythemia vera. A case report". Blut. 48 (3 ...
*  Erythropoietin receptor
Mutations in Jak2 kinases associated with EpoR can also lead to polycythemia vera. Primary role of EpoR is to promote ... "A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera". Nature. 434 (7037): 1144-8. doi: ...
*  Allen C Eaves
Unregulated proliferation of primitive neoplastic progenitor cells in long-term polycythemia vera marrow cultures. J Clin ... dose-response curves for three classes of erythroid progenitors in normal and in patients with polycythemia vera. Blood 52: ... Hematopoietic stem cells Cellular therapy Bone marrow transplantation Chronic myelogenous leukemia Polycythemia vera Terry Fox ...
*  Clonal hypereosinophilia
Patients with the polycythemia vera form of the disease have been treated by reducing the circulating red blood cell load by ... polycythemia vera; three cases resembled acute myelogenous leukemia; and one case presented with findings of a combined ... with ETV6-ACSL6 gene fusion in polycythemia vera". Leukemia. 20 (6): 1175-8. doi:10.1038/sj.leu.2404194. PMID 16572202. ...
*  ACSL6
2006). "t(5;12)(q23-31;p13) with ETV6-ACSL6 gene fusion in polycythemia vera". Leukemia. 20 (6): 1175-8. doi:10.1038/sj.leu. ...
*  Malar flush
It can also be associated with other conditions, such as SLE or polycythemia rubra vera. Topol, Eric J; Califf, Robert M (2007 ...
*  Hydroxycarbamide
... is used for the following indications: Myeloproliferative disease (primarily polycythemia vera and essential ... and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects ...